Jul 15, 2024   SOURCE: PR NewsWire

Metabolomics Technologies Market Expected to Reach $30.2 Billion by 2029

BCC Research Projects 13.1% CAGR from 2024, with Market Growing from $16.4 Billion in 2024 to $30.2 Billion by 2029

BOSTON, July 15, 2024 /PRNewswire/ -- Metabolomics: Technologies and Global Markets is about studying tiny molecules in our bodies to understand health and disease better. It looks at advanced tools used for this research and how they're being adopted worldwide. The report covers market trends, key companies, and future opportunities in the field, showing how metabolomics is making a big impact on science and industry.

https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

Market Expansion and Revenue Surge

"According to the latest BCC research study, the demand for Metabolomics: Technologies and Global Markets expected to grow from $16.4 billion in 2024 and will reach $30.2 billion by the end of 2029 at a compound annual growth rate (CAGR) of 13.1% from 2024 to 2029."

This report thoroughly examines the global market for metabolomics technologies. It estimates both current and past market revenues, breaking them down by product type, medical conditions, applications, and regions.

Some Interesting Facts about Green Tires Market

Metabolomics can identify unique metabolic patterns in forensic investigations and predict how individuals will respond to medications, enabling personalized treatment plans. It can also analyze breath samples for non-invasive disease diagnosis and detect metabolic changes related to aging and psychological conditions, improving diagnostics and treatments.

Factors contributing to this growth include:

    1. Technological advancements.: Technological advancements are improvements
       in tools and methods that make tasks easier and more efficient, like
       smartphones, faster computers, or advanced medical devices. They help us
       solve problems and improve our daily lives.


    2. Increasing healthcare expenditure.: Increasing healthcare expenditure
       means that more money is being spent on healthcare services, treatments,
       and medications. This can be due to factors like an aging population, new
       medical technologies, and rising costs of healthcare services.


    3. Precision medicine and personalized healthcare.: Precision medicine and
       personalized healthcare mean tailoring medical treatments and
       interventions to individual characteristics such as genetics, lifestyle,
       and environment. Instead of a one-size-fits-all approach, doctors use
       information specific to each person to make decisions about prevention,
       diagnosis, and treatment, aiming to achieve better outcomes and reduce
       side effects.
    4. Drug discovery and development.: Drug discovery and development is the
       process of finding new medications and bringing them to market. It
       involves identifying potential drug candidates, testing their safety and
       effectiveness through clinical trials, and obtaining regulatory approval
       before they can be prescribed to patients. This process can take many
       years and involves collaboration between scientists, researchers,
       clinicians, and regulatory agencies to ensure that new drugs are safe and
       effective for treating diseases.

Request a Sample Copy of the Metabolomics: Technologies and Global Markets

Report Synopsis



     
              Report Metrics  
     
              Details



     Base year considered                                                                                               2023



     Forecast Period considered 
     2024-2029



     Base year market size                                                                            
            $14.7 billion



     Market Size Forecast                                                                             
            $30.2 billion



     Growth Rate                
     CAGR of 13.1% for the forecast period of 2024-2029



     Segment Covered            
     Product, Indication, Application, and Region



     Regions covered            
     North America, Europe, Asia-Pacific, and Rest of the World (RoW)



     Countries covered            China, India, Japan, Malaysia, Singapore U.S., Canada, Mexico, Germany, U.K.,
                                    France, Italy, and Spain



     Key Market Drivers

                                               Technological advancements.
            
            
               Increasing healthcare
                                                expenditure.
            
            
               Precision medicine and personalized
                                                healthcare.
            
            
               Drug discovery and development.

Market Segmentation

The Global Market for Metabolomics: Technologies and Global Markets can be categorized into various segments:

    --  By ProductIn metabolomics, technologies are divided into two main
        categories: separation techniques and detection techniques. Separation
        techniques, like chromatography (GC and LC), isolate individual
        metabolites from complex mixtures for easier analysis. Detection
        techniques, such as mass spectrometry (MS) and NMR spectroscopy, then
        identify and measure these metabolites, providing detailed insights into
        their structures and quantities. Together, these methods enable
        researchers to explore and understand the intricate biochemical
        processes in living organisms.



    --  By IndicationIn metabolomics, studies are categorized by various health
        conditions, including cancer, cardiovascular disorders, neurological
        disorders, inborn errors of metabolism, and others. Researchers use
        metabolomics to identify unique metabolic patterns associated with these
        conditions. For instance, in cancer, it helps detect specific metabolic
        changes that may aid in early diagnosis or monitoring treatment
        responses. In cardiovascular and neurological disorders, it offers
        insights into metabolic disturbances linked to disease progression. For
        inborn errors of metabolism, it assists in understanding and managing
        genetic disorders affecting metabolic pathways. These insights
        contribute to developing more targeted therapies and personalized
        treatment approaches across different medical conditions.



    --  By ApplicationIn metabolomics, applications span biomarker discovery,
        drug development, toxicology testing, nutrigenomics, functional
        genomics, and other areas. Biomarker discovery involves identifying
        specific molecules that indicate disease presence or treatment response.
        Drug discovery uses metabolomics to find potential new medications by
        studying metabolic pathways. Toxicology testing assesses how substances
        affect metabolism and health. Nutrigenomics examines how nutrients
        influence metabolism and genetics. Functional genomics studies how genes
        interact with metabolites to understand biological functions. These
        applications enhance our understanding of health, disease, and
        personalized medicine through detailed metabolic analysis.

    --  By RegionMetabolomics technologies are utilized across different
        regions: North America, Europe, APAC (Asia-Pacific), and the Rest of
        World. Each region contributes uniquely to the adoption and advancement
        of these technologies in research, healthcare, and industry. North
        America and Europe are leaders in innovation and market adoption, with
        extensive research and development activities. APAC is rapidly growing,
        driven by increasing healthcare investments and research initiatives.
        The Rest of World region encompasses diverse contributions and emerging
        markets, fostering global collaboration in metabolomics research and
        applications.

this report on global market for metabolomics: technologies and global markets provides comprehensive insights and analysis, addressing the following key questions:

    1. What is the projected market size and growth rate of the Metabolomics
       Technologies market?The global medical robotics and computer-assisted
       surgery market is projected to grow from $14.4 billion in 2023 to $30.2
       billion in 2029 at a compound annual growth rate (CAGR) of 13.1 % during
       the forecast period.



    2. What are the key factors driving the growth of the Metabolomics
       Technologies market?The growth of the metabolomics technologies market is
       propelled by advancements in analytical techniques, expanding
       applications in clinical research and personalized nutrition, increasing
       integration into pharmaceutical and biotechnology research, and rising
       demand in agriculture and food sciences.



    3. What segments are covered in the global Metabolomics Technologies
       market?The global Metabolomics Technologies market is segmented based on
       the product type, Indication, application and geographic region.



    4. By Type, which segment will dominate the market by the end of 2028?The
       surgical robotics systems segment will dominate the market by the end of
       2028.

    5. Which region has the highest market share in the Metabolomics
       Technologies market?North America holds the highest share in the market.

Some of the Key Market Players Are:

    --  AGILENT TECHNOLOGIES INC.
    --  BIO-RAD LABORATORIES INC.
    --  BRUKER
    --  DANAHER CORP
    --  MERCK KGAA
    --  SHIMADZU CORP.
    --  THERMO FISHER SCIENTIFIC INC.
    --  WATERS CORP.

Directly Purchase a copy of the report with BCC Research.

For further information or to make a purchase, please get in touch with info@bccresearch.com.

About BCC Research

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts' goal is to help you make informed business decisions, free of noise and hype.

Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301
For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/metabolomics-technologies-market-expected-to-reach-30-2-billion-by-2029--302196718.html

SOURCE BCC Research LLC